Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 216

    1.

    Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin.

    McHayleh W, Sehgal R, Redner RL, Raptis A, Agha M, Natale J, Luong TM, Schlesselman JJ, Foon KA, Boyiadzis M.

    Leuk Lymphoma. 2009 Nov;50(11):1848-53.PMID: 19860628 [PubMed - in process]Related articles

    2.

    Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors.

    Szczepanski MJ, Szajnik M, Welsh A, Foon KA, Whiteside TL, Boyiadzis M.

    Cancer Immunol Immunother. 2010 Jan;59(1):73-9. Epub 2009 Jun 13.PMID: 19526239 [PubMed - in process]Related articles

    3.

    Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia.

    Szczepanski MJ, Szajnik M, Czystowska M, Mandapathil M, Strauss L, Welsh A, Foon KA, Whiteside TL, Boyiadzis M.

    Clin Cancer Res. 2009 May 15;15(10):3325-32. Epub 2009 May 5.PMID: 19417016 [PubMed - indexed for MEDLINE]Related articles

    4.

    Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia.

    Foon KA, Boyiadzis M, Land SR, Marks S, Raptis A, Pietragallo L, Meisner D, Laman A, Sulecki M, Butchko A, Schaefer P, Lenzer D, Tarhini A.

    J Clin Oncol. 2009 Feb 1;27(4):498-503. Epub 2008 Dec 15.PMID: 19075274 [PubMed - indexed for MEDLINE]Related articles

    5.

    Stimulatory effects of CpG oligodeoxynucleotide on dendritic cell-based immunotherapy of colon cancer in CEA/HLA-A2 transgenic mice.

    Saha A, Bhattacharya-Chatterjee M, Foon KA, Celis E, Chatterjee SK.

    Int J Cancer. 2009 Feb 15;124(4):877-88.PMID: 19035460 [PubMed - indexed for MEDLINE]Related articles

    6.

    Chronic lymphocytic leukemia (CLL) cells genetically modified to express B7-1, ICAM-1, and LFA-3 confer APC capacity to T cells from CLL patients.

    Litzinger MT, Foon KA, Sabzevari H, Tsang KY, Schlom J, Palena C.

    Cancer Immunol Immunother. 2009 Jun;58(6):955-65. Epub 2008 Nov 14.PMID: 19009294 [PubMed - indexed for MEDLINE]Related articles

    7.

    Phase II trial of short-course CHOP-R followed by 90Y-ibritumomab tiuxetan and extended rituximab in previously untreated follicular lymphoma.

    Jacobs SA, Swerdlow SH, Kant J, Foon KA, Jankowitz R, Land SR, DeMonaco N, Joyce J, Osborn JL, Evans TL, Schaefer PM, Luong TM.

    Clin Cancer Res. 2008 Nov 1;14(21):7088-94.PMID: 18981007 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Radioisotopic localization of (90)Yttrium-ibritumomab tiuxetan in patients with CD20+ non-Hodgkin's lymphoma.

    Jacobs SA, Harrison AM, Swerdlow SH, Foon KA, Avril N, Vidnovic N, Joyce J, DeMonaco N, McCarty KS Jr.

    Mol Imaging Biol. 2009 Jan-Feb;11(1):39-45. Epub 2008 Sep 5.PMID: 18773247 [PubMed - indexed for MEDLINE]Related articles

    9.

    Approved monoclonal antibodies for cancer therapy.

    Boyiadzis M, Foon KA.

    Expert Opin Biol Ther. 2008 Aug;8(8):1151-8. Review.PMID: 18613766 [PubMed - indexed for MEDLINE]Related articles

    10.

    Carcinoembryonic antigen transgenic mouse models for immunotherapy and development of cancer vaccines.

    Bhattacharya-Chatterjee M, Saha A, Foon KA, Chatterjee SK.

    Curr Protoc Immunol. 2008 Feb;Chapter 20:Unit 20.8. Review.PMID: 18432635 [PubMed - indexed for MEDLINE]Related articles

    11.

    Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia.

    Lee JJ, Foon KA, Mailliard RB, Muthuswamy R, Kalinski P.

    J Leukoc Biol. 2008 Jul;84(1):319-25. Epub 2008 Apr 21.PMID: 18426971 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Flow cytometric immunophenotyping for hematologic neoplasms.

    Craig FE, Foon KA.

    Blood. 2008 Apr 15;111(8):3941-67. Epub 2008 Jan 15. Review.PMID: 18198345 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Generation of Her-2/neu vaccine utilizing idiotypic network cascade.

    Pal S, Saha A, Mohanty K, Mallick P, Chatterjee SK, Foon KA, Bhattacharya-Chatterjee M.

    Cancer Biol Ther. 2007 Dec;6(12):1916-25. Epub 2007 Sep 1.PMID: 18059165 [PubMed - indexed for MEDLINE]Related articles

    14.

    Hematopoietic stem cell transplantation for chronic lymphocytic leukemia: potential cure for an incurable disease.

    Boyiadzis M, Foon KA, Pavletic S.

    Expert Opin Biol Ther. 2007 Dec;7(12):1789-97. Review.PMID: 18034645 [PubMed - indexed for MEDLINE]Related articles

    15.

    The expanding role of rituximab and radioimmunotherapy in the treatment of B-cell lymphomas.

    Jacobs SA, Foon KA.

    Expert Opin Biol Ther. 2007 Nov;7(11):1749-62. Review.PMID: 17961097 [PubMed - indexed for MEDLINE]Related articles

    16.

    Translational research: advancing medical science by stimulating interdisciplinary research.

    Foon KA.

    Exp Biol Med (Maywood). 2007 Jun;232(6):713-4. No abstract available. PMID: 17526762 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.
    18.

    NK cells in cancer immunotherapy: three decades of discovery.

    Boyiadzis M, Foon KA, Herberman RB.

    Discov Med. 2006 Dec;6(36):243-8.PMID: 17250791 [PubMed - in process]Related articles

    19.

    Anti-tumor immunity induced by an anti-idiotype antibody mimicking human Her-2/neu.

    Mohanty K, Saha A, Pal S, Mallick P, Chatterjee SK, Foon KA, Bhattacharya-Chatterjee M.

    Breast Cancer Res Treat. 2007 Jul;104(1):1-11. Epub 2006 Sep 27.PMID: 17004107 [PubMed - indexed for MEDLINE]Related articles

    20.

    Natural killer cells: from bench to cancer therapy.

    Boyiadzis M, Foon KA.

    Expert Opin Biol Ther. 2006 Oct;6(10):967-70. Review.PMID: 16989578 [PubMed - indexed for MEDLINE]Related articles

    21.

    Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.

    Saha A, Chatterjee SK, Foon KA, Bhattacharya-Chatterjee M.

    Immunology. 2006 Aug;118(4):483-96. Erratum in: Immunology. 2006 Sep;119(1):143. PMID: 16895556 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Biological therapies: twenty-five years of progress in cancer therapy.

    Foon KA.

    Cancer Biol Ther. 2006 Mar;5(3):331-4. Epub 2006 Mar 20. No abstract available. PMID: 16479152 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL.

    Brickner AG, Evans AM, Mito JK, Xuereb SM, Feng X, Nishida T, Fairfull L, Ferrell RE, Foon KA, Hunt DF, Shabanowitz J, Engelhard VH, Riddell SR, Warren EH.

    Blood. 2006 May 1;107(9):3779-86. Epub 2006 Jan 3.PMID: 16391015 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706.

    Hussein MA, Gundacker H, Head DR, Elias L, Foon KA, Boldt DH, Dobin SM, Dakhil SR, Budd GT, Appelbaum FR.

    Leukemia. 2005 Nov;19(11):1880-6.PMID: 16193091 [PubMed - indexed for MEDLINE]Related articles

    25.

    Monoclonal antibody therapy of leukaemias and lymphomas.

    Jacobs SA, Foon KA.

    Expert Opin Biol Ther. 2005 Sep;5(9):1225-43. Review.PMID: 16120052 [PubMed - indexed for MEDLINE]Related articles

    26.

    Potential approach to immunotherapy of chronic lymphocytic leukemia (CLL): enhanced immunogenicity of CLL cells via infection with vectors encoding for multiple costimulatory molecules.

    Palena C, Foon KA, Panicali D, Yafal AG, Chinsangaram J, Hodge JW, Schlom J, Tsang KY.

    Blood. 2005 Nov 15;106(10):3515-23. Epub 2005 Aug 4.PMID: 16081691 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    CpG oligonucleotides enhance the tumor antigen-specific immune response of an anti-idiotype antibody-based vaccine strategy in CEA transgenic mice.

    Saha A, Baral RN, Chatterjee SK, Mohanty K, Pal S, Foon KA, Primus FJ, Krieg AM, Weiner GJ, Bhattacharya-Chatterjee M.

    Cancer Immunol Immunother. 2006 May;55(5):515-27. Epub 2005 Jul 26.PMID: 16044253 [PubMed - indexed for MEDLINE]Related articles

    28.

    Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice.

    Saha A, Chatterjee SK, Foon KA, Primus FJ, Sreedharan S, Mohanty K, Bhattacharya-Chatterjee M.

    Cancer Res. 2004 Jul 15;64(14):4995-5003.PMID: 15256474 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer.

    Rowinsky EK, Schwartz GH, Gollob JA, Thompson JA, Vogelzang NJ, Figlin R, Bukowski R, Haas N, Lockbaum P, Li YP, Arends R, Foon KA, Schwab G, Dutcher J.

    J Clin Oncol. 2004 Aug 1;22(15):3003-15. Epub 2004 Jun 21.PMID: 15210739 [PubMed - indexed for MEDLINE]Related articles

    30.

    Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody.

    Foon KA, Yang XD, Weiner LM, Belldegrun AS, Figlin RA, Crawford J, Rowinsky EK, Dutcher JP, Vogelzang NJ, Gollub J, Thompson JA, Schwartz G, Bukowski RM, Roskos LK, Schwab GM.

    Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):984-90. Review.PMID: 14967460 [PubMed - indexed for MEDLINE]Related articles

    31.

    Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.

    Saha A, Chatterjee SK, Foon KA, Primus FJ, Bhattacharya-Chatterjee M.

    Cancer Res. 2003 Jun 1;63(11):2844-54.PMID: 12782590 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Immunostimulatory CpG oligonucleotides enhance the immune response of anti-idiotype vaccine that mimics carcinoembryonic antigen.

    Baral RN, Saha A, Chatterjee SK, Foon KA, Krieg AM, Weiner GJ, Bhattacharya-Chatterjee M.

    Cancer Immunol Immunother. 2003 May;52(5):317-27. Epub 2003 Mar 5.PMID: 12700947 [PubMed - indexed for MEDLINE]Related articles

    33.

    Use of the anti-idiotype breast cancer vaccine 11D10 in conjunction with autologous stem cell transplantation in patients with metastatic breast cancer.

    Reece DE, Foon KA, Bhattarcharya-Chatterjee M, Adkins D, Broun ER, Connaghan DG, Dipersio JF, Holland HK, Howard DA, Hale GA, Klingemann HG, Munn RK, Raptis A, Phillips GL.

    Clin Breast Cancer. 2003 Feb;3 Suppl 4:S152-7.PMID: 12620153 [PubMed - indexed for MEDLINE]Related articles

    34.

    Anti-idiotype antibody vaccine therapy for cancer.

    Bhattacharya-Chatterjee M, Chatterjee SK, Foon KA.

    Expert Opin Biol Ther. 2002 Dec;2(8):869-81. Review.PMID: 12517266 [PubMed - indexed for MEDLINE]Related articles

    35.

    Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas.

    Rohatgi N, LaRocca RV, Bard V, Sethuraman G, Foon KA.

    Am J Hematol. 2002 Jul;70(3):181-5.PMID: 12111762 [PubMed - indexed for MEDLINE]Related articles

    36.

    Interim analysis of the use of the anti-idiotype breast cancer vaccine 11D10 (TriAb) in conjunction with autologous stem cell transplantation in patients with metastatic breast cancer.

    Reece DE, Foon KA, Battacharya-Chatterjee M, Adkins D, Broun ER, Connaghan DG, Dipersio JF, Holland HK, Howard DS, Hale GA, Klingemann HG, Munn RK, Raptis A, Phillips GL.

    Clin Breast Cancer. 2001 Apr;2(1):52-8.PMID: 11899383 [PubMed - indexed for MEDLINE]Related articles

    37.

    Gene therapy for head and neck cancer using vaccinia virus expressing IL-2 in a murine model, with evidence of immune suppression.

    Qin H, Valentino J, Manna S, Tripathi PK, Bhattacharya-Chatterjee M, Foon KA, O'Malley BW Jr, Chatterjee SK.

    Mol Ther. 2001 Dec;4(6):551-8.PMID: 11735339 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Tumor associated antigen (TAA) mimicry and immunotherapy of malignant diseases from anti-idiotypic antibodies to peptide mimics.

    Wang X, Luo W, Foon KA, Ferrone S.

    Cancer Chemother Biol Response Modif. 2001;19:309-26. Review. No abstract available. PMID: 11686020 [PubMed - indexed for MEDLINE]Related articles

    40.

    Murine monoclonal anti-idiotypic antibody as a surrogate antigen for human Her-2/neu.

    Baral R, Sherrat A, Das R, Foon KA, Bhattacharya-Chatterjee M.

    Int J Cancer. 2001 Apr 1;92(1):88-95.PMID: 11279611 [PubMed - indexed for MEDLINE]Related articles

    41.

    Adjuvant immunotherapy for melanoma and colorectal cancers.

    Safa MM, Foon KA.

    Semin Oncol. 2001 Feb;28(1):68-92. Review.PMID: 11254868 [PubMed - indexed for MEDLINE]Related articles

    42.

    Immunotherapy for colorectal cancer.

    Foon KA.

    Curr Oncol Rep. 2001 Mar;3(2):116-26. Review.PMID: 11177743 [PubMed - indexed for MEDLINE]Related articles

    43.

    The anti-idiotype vaccines for immunotherapy.

    Bhattacharya-Chatterjee M, Chatterjee SK, Foon KA.

    Curr Opin Mol Ther. 2001 Feb;3(1):63-9. Review.PMID: 11249733 [PubMed - indexed for MEDLINE]Related articles

    44.

    Construction and characterization of DNA vaccines encoding the single-chain variable fragment of the anti-idiotype antibody 1A7 mimicking the tumor-associated antigen disialoganglioside GD2.

    Zeytin HE, Tripathi PK, Bhattacharya-Chatterjee M, Foon KA, Chatterjee SK.

    Cancer Gene Ther. 2000 Nov;7(11):1426-36.PMID: 11129285 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Monoclonal antibody therapies for lymphomas.

    Foon KA.

    Cancer J. 2000 Sep-Oct;6(5):273-8. Review.PMID: 11079163 [PubMed - indexed for MEDLINE]Related articles

    46.

    Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer.

    Reece DE, Foon KA, Bhattacharya-Chatterjee M, Hale GA, Howard DS, Munn RK, Nath R, Plummer BA, Teitelbaum A, Phillips GL.

    Bone Marrow Transplant. 2000 Oct;26(7):729-35.PMID: 11042653 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Anti-idiotype vaccine against cancer.

    Bhattacharya-Chatterjee M, Chatterjee SK, Foon KA.

    Immunol Lett. 2000 Sep 15;74(1):51-8. Review.PMID: 10996628 [PubMed - indexed for MEDLINE]Related articles

    48.

    Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.

    Bhattachary-Chatterjee M, Nath Baral R, Chatterjee SK, Das R, Zeytin H, Chakraborty M, Foon KA.

    Cancer Immunol Immunother. 2000 Jun;49(3):133-41. Review.PMID: 10881692 [PubMed - indexed for MEDLINE]Related articles

    49.

    Clinical and immune responses in advanced melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2.

    Foon KA, Lutzky J, Baral RN, Yannelli JR, Hutchins L, Teitelbaum A, Kashala OL, Das R, Garrison J, Reisfeld RA, Bhattacharya-Chatterjee M.

    J Clin Oncol. 2000 Jan;18(2):376-84.PMID: 10637253 [PubMed - indexed for MEDLINE]Related articles

    50.

    Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.

    Foon KA, John WJ, Chakraborty M, Das R, Teitelbaum A, Garrison J, Kashala O, Chatterjee SK, Bhattacharya-Chatterjee M.

    J Clin Oncol. 1999 Sep;17(9):2889-5.PMID: 10561367 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...